- Home
- AZN vs SCHW Comparison
AZN vs SCHW Comparison
Compare AZN & SCHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AZN | SCHW |
|---|---|---|
| Founded | 1992 | 1971 |
| Country | United Kingdom | United States |
| Employees | N/A | 32700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.7B | 167.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AZN | SCHW |
|---|---|---|
| Price | $192.18 | $93.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | N/A | ★ $114.25 |
| AVG Volume (30 Days) | 1.7M | ★ 8.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.69% | 1.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.13 | $12.83 |
| Revenue Next Year | $6.21 | $8.79 |
| P/E Ratio | $31.91 | ★ $20.51 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.24 | $65.88 |
| 52 Week High | $212.71 | $107.50 |
Technical Indicators
Market Signals| Indicator | AZN | SCHW |
|---|---|---|
| Relative Strength Index (RSI) | 57.42 | 43.30 |
| Support Level | $89.28 | $91.05 |
| Resistance Level | $211.32 | $97.86 |
| Average True Range (ATR) | 3.16 | 2.18 |
| MACD | -4.83 | 0.01 |
| Stochastic Oscillator | 13.41 | 41.80 |
Price Performance
Historical ComparisonAbout AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
About SCHW Charles Schwab Corporation (The)
Charles Schwab is one of the largest retail-oriented financial-services companies in the US, with $11.9 trillion in client assets across its brokerage, banking, asset management, custody, financial advisory, and wealth-management businesses at the end of 2025. While best known for its retail brokerage offering, Schwab generates the lion's share of its revenue and profits through its Charles Schwab Bank and asset management segments. The firm is a dominant player in registered investment advisor custody, with over 40% market share, and has recently pushed into wealth management with robo-advisory, direct indexing, and other managed-investment solutions.